Taiwan FDA registration c643c8814b1296495976f3a68344b2cd
Abbott second-generation albumin BCP assay set
TW: 亞培第二代白蛋白BCP檢驗試劑組
Taiwan·Risk Class 2·ABBOTT IRELAND DIAGNOSTICS DIVISION·Registered Jan 20, 2022 – Jan 20, 2027ActiveRegistration details
- Analysis ID
- c643c8814b1296495976f3a68344b2cd
- Customs Code
- DHA05603520807
Company information
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Manufacturer Country
- Ireland
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product is used to quantify albumin in human serum or plasma on the Alinity c System.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1035 Albumin Testing System
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Jan 20, 2022
- Expiry Date
- Jan 20, 2027
About this record
Access comprehensive regulatory information for Abbott second-generation albumin BCP assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c643c8814b1296495976f3a68344b2cd and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices